Drug Development

25 - 36 of 37 listings
Listings
  • A20

    A20

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6292J Description Mouse cell line derived from lymphoma. Species Mus musculus (Mouse) Recommended Medium RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/a20-item-csc-c6292j-42892.htm

  • BA/F3

    BA/F3

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    IL-3 dependent murine pro B cell line; the precise origin of the cell line is unclear; however, performing May-Grünwald-Giemsa staining provides evidence that the cells are indeed from a lymphatic back ground. Cells were apparently not derived from B...

  • 32D

    32D

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from long-term bone marrow cultures of C3H/HeJ mice infected with the Friend murine leukemia virus; cells are constitutively growth factor-dependent https://www.creative-bioarray.com/32D-CSC-C1101-item-1563.htm

  • WEHI 231

    WEHI 231

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9260W Description Mineral oil induced tumor in (BALB/c x NZB)F1 mice Species Mus musculus (Mouse) Recommended Medium DMEM + 0.05mM 2-Mercaptoethanol (2ME) + 10% Foetal Bovine Serum (h.i.FBS). https://www.creative-bioarray.com/WEHI-231-CS...

  • Hepa 1-clc7

    Hepa 1-clc7

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Species: mouse, C57L; Tissue: liver; Tumor: hepatoma, BW7756; Derived from: Hepa-1cl, cloned from the Hepa-1 cell line https://www.creative-bioarray.com/Hepa-1-clc7-CSC-6264W-item-1508.htm

  • B16F10/mGM

    B16F10/mGM

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6409J Description Mouse GM-CSF producing B16 melanoma. Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/b16f10-mgm-item-csc-c6409j-43009.htm

  • B16 BL6

    B16 BL6

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9334L Description Histopathology: melanoma Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/B16-BL6-CSC-C9334L-item-39481.htm

  • ACA652 Probe

    ACA652 Probe

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. FBPC-53 Description The identification of microbes: Acinetobacter Size 50 Tests Usage For Research Use Only. Not for use in diagnostic procedures. Storage Store at minus 20 centigrade https://www.creative-bioarray.com/aca652-probe-item-fbpc-5...

  • RH-30

    RH-30

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from the bone marrow metastasis of a 17-year-old man with undifferentiated (standard classification) or unclassified (Palmer classification) alveolar rhabdomyosarcoma; cells were described as carrying a p53 mutation, expressing high level...

  • UKE-1

    UKE-1

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C2301J Description established from peripheral blood of a 59-year-old woman with Essential thrombocythemia Species Homo sapiens (Human) Source Blood; Peripheral Blood Recommended Medium RPMI- 1640 with 2mM L-glutamine + 20% FBS https://ww...

  • MPP 89

    MPP 89

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-6299W Description Species: human male 67 years old; Tissue: pleural effusion; Tumor: mesothelioma Species Homo sapiens (Human) Source Pleural Effusion https://www.creative-bioarray.com/MPP-89-CSC-6299W-item-1022.htm

  • 143B

    143B

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9149W Description This is a human osteosarcoma cell line, thymidine kinase negative (TK-) Species Homo sapiens (Human) Source Bone https://www.creative-bioarray.com/143B-CSC-C9149W-item-42082.htm